Lipegfilgrastim 相關新聞
Lipegfilgrastim 目前有 6 則相關新聞報導,預測適應症 20 個。
本頁整合 Lipegfilgrastim 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Lonquex is indicated in adults and in children 2 years of age and older for reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic...
- 證據等級:L5
- 預測適應症(20 個):
- primary release disorder of platelets(99.9%)
- severe nonproliferative diabetic retinopathy(99.9%)
- pseudo-von Willebrand disease(99.9%)
- Glanzmann thrombasthenia(99.9%)
- diabetic retinopathy(99.8%)
- hemorrhagic disorder due to a constitutional thrombocytopenia(99.0%)
- thrombocytopenia due to immune destruction(99.0%)
- bleeding diathesis due to a collagen receptor defect(98.9%)
- Scott syndrome(98.8%)
- drug-induced osteoporosis(98.6%)
- fetal and neonatal alloimmune thrombocytopenia(98.5%)
- neonatal thrombocytopenia(98.2%)
- HER2 positive breast carcinoma(97.8%)
- dermatitis(97.8%)
- autoimmune thrombocytopenic(97.7%)
- diabetic cataract(97.6%)
- platelet-type bleeding disorder(97.5%)
- seborrheic dermatitis(96.9%)
- acrodermatitis chronica atrophicans(96.8%)
- Ehlers-Danlos syndrome, fibronectinemic type(96.8%)
相關新聞(6 則)
Los determinantes sociales marcan el control de la diabetes más allá del tratamiento - El médico interactivo
2026-04-27 diabetes
Virtual Reality zur Diabetes-Bekämpfung: Forscher tüfteln an Gesundheitsprojekt
2026-04-27 diabetes
來源:Stimme
Cuando el corazón, los riñones y el metabolismo empeoran y tienes diabetes aumenta el riesgo de cáncer - La Razón
2026-04-27 diabetes
來源:La Razón
Diabetes-Prävention: Gen-Tests zeigen, wer von Vitamin D profitiert - AD HOC NEWS
2026-04-27 diabetes
來源:AD HOC NEWS
SGLT-2-Hemmer: Neue Ära in der Diabetes-Therapie - AD HOC NEWS
2026-04-27 diabetes
來源:AD HOC NEWS
El trabajo a turnos incrementa el riesgo para la salud: del insomnio a la diabetes o el cáncer - La Voz de Galicia
2026-04-26 diabetes
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。